These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Purine analogs in the treatment of chronic lymphocytic leukemia.
    Author: Pott C, Hiddemann W.
    Journal: Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834.
    Abstract:
    The purine analogs fludarabine (FAMP) and 2-chlorodeoxyadenosine (2-CDA) are highly active in chronic lymphocytic leukemia (CLL). In second-line therapy response rates are in the range of 30 to 60% and exceed 70% when applied to previously untreated patients. While FAMP in particular is thus well established for salvage treatment and can be considered as the present treatment of choice, more data are needed to define the role of purine analogs for first-line therapy.
    [Abstract] [Full Text] [Related] [New Search]